Caris Life Sciences has developed a genetic test that aims to simplify care for people with a group of…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
PANCREATIC CANCER
Electrical therapy shows promise for metastatic pancreatic cancer
A type of electrical therapy called Tumor Treating Fields (TTFields), given in combination with chemotherapy and other medication, may help…
GYNECOLOGICAL CANCER
FDA fast tracks treatment for advanced, resistant ovarian cancer
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to the experimental therapy ZW191 as a potential treatment…
A European Medicines Agency (EMA) panel has recommended approval of a subcutaneous (under-the-skin) version of Sarclisa (isatuximab), an approved…
Adding Amplia Therapeutics‘ experimental drug narmafotinib to standard chemotherapy led to complete responses — meaning no detectable cancer on…
Most doctors who treat multiple myeloma expect that CAR T-cell therapies will soon became the standard first-line treatment,…
Tempus AI, a technology company focused on advancing precision medicine using artificial intelligence (AI), has announced a strategic collaboration…
PANCREATIC CANCER
New AI-based tool aims to help guide treatment for pancreatic cancer
Caris Life Sciences has launched a new diagnostic tool that aims to help guide treatment decisions for people with…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to AMXT 1501 to treat…
GYNECOLOGICAL CANCER
New CAR-NKT cell therapy targets endometrial cancer on two fronts
Researchers have developed a new cell therapy that aims to treat endometrial cancer by targeting cancer cells while also depleting…